Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kaléo
Pharma
GSK, Amneal and Kaleo walk back patents after FTC's challenge
GSK, Amneal and Kaleo have removed patents from the FDA Orange Book following the FTC's recent challenge.
Angus Liu
Dec 21, 2023 11:08am
EpiPen rival Kaléo snapped up in $310M deal
Nov 30, 2021 9:35am
Trump's pick for $354M manufacturing deal could raise eyebrows
May 21, 2020 12:09pm
Adamis sues rival epinephrine maker Kaléo for cybersquatting
Jul 2, 2019 10:58am
Novartis, Adamis keep swinging at EpiPen with new Symjepi dose
Sep 28, 2018 11:06am
With EpiPen competitors bearing down, can Mylan maintain its lead?
Sep 18, 2018 12:08pm